<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="uz">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/researchfocus.v3i4.2655</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-013589</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>14.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="uz">2-TIP QANDLI DIABETNI DAVOLASHDA GLIMAKS ( GLIMEPIRID) PREPARATINING QO‘LLANILISHI.</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>THE USE OF THE DRUG GLIMAX ( GLIMEPIRIDE) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS.</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="ru">
          <trans-title>ПРИМЕНЕНИЕ ПРЕПАРАТА ГЛИМАКС ( ГЛИМЕПИРИД) ПРИ ЛЕЧЕНИИ САХАРНОГО ДИАБЕТА 2 ТИПА.</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <string-name>Narmetova Sevara Yangiboyevna</string-name>
          <aff>Samarqand Davlat Tibbiyot Universiteti Farmakologiya kafedrasi assistenti</aff>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Mardiyeva Jasmina Sayfullo qizi</string-name>
          <aff>Samarqand Davlat Tibbiyot Universiteti Pediatriya fakulteti 303-guruh talabasi</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2024-05-05">
        <day>05</day>
        <month>05</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2024</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>66</fpage>
      <lpage>70</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0</ali:license_ref>
          <license-p>Ushbu asar Creative Commons Attribution 4.0 International litsenziyasi asosida litsenziyalangan.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-013589/"/>
      <abstract xml:lang="uz">
        <p>Mazkur maqola tibbiyotda keng tarqalgan 2- tur qandli diabet kasalligi haqida bo‘lib bu-kasallik moddalar almashinuvi buzilishi bilan bog‘liqdir. Bu kasallik turli sabablarga ko‘ra rivojlanadi. Kasallikning ayrim turlari genetik kelib chiqishga ega, boshqalari turmush tarzi,stres yoki atrof-muhit omillari bilan bog‘liq. 2019- yilda qandli diabet dunyo bo‘ylab 1,5 million o‘limning bevosita sababi bo‘lgan.Bundan tashqari, xolatlarning deyarli yarmida kasallik 60-70 yoshgacha bo‘lgan odamlarda o‘lim bilan yakullangan. O‘limning asosiy sabablari asoratlar(nefropatiya, neyropatiya, retinopatiya, diabetik oyoq va boshqalar) bilan bog‘liq</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>This article is about type 2 diabetes, which is common in medicine and is associated with metabolic disorders. This disease develops for various reasons. Some types of the disease have a genetic origin, others are related to lifestyle, stress or environmental factors. In 2019, diabetes was the direct cause of 1.5 million deaths worldwide. In addition, in almost half of the cases, the disease ended with death in people under 60-70 years of age. The main causes of death are related to complications (nephropathy, neuropathy, retinopathy, diabetic foot, etc.)</p>
      </trans-abstract>
      <trans-abstract xml:lang="ru">
        <p>Эта статья о диабете 2 типа, который распространен в медицине и связан с нарушением обмена веществ. Это заболевание развивается по разным причинам. Некоторые виды заболевания имеют генетическое происхождение, другие связаны с образом жизни, стрессом или факторами окружающей среды. В 2019 году диабет стал непосредственной причиной 1,5 млн смертей во всем мире, причем почти в половине случаев заболевание заканчивалось смертью у людей до 60-70 лет. Основные причины смерти связаны с осложнениями (нефропатия, нейропатия, ретинопатия, диабетическая стопа и др.).</p>
      </trans-abstract>
      <kwd-group xml:lang="uz">
        <kwd>Qandli diabet</kwd>
        <kwd>giperglikemiya</kwd>
        <kwd>glibenklamid</kwd>
        <kwd>glikozillangan gemoglobin</kwd>
        <kwd>glukoza</kwd>
        <kwd>Insulin</kwd>
        <kwd>gipoglikemiya</kwd>
      </kwd-group>
      <kwd-group xml:lang="en">
        <kwd>Diabetes Mellitus</kwd>
        <kwd>Hyperglycemia</kwd>
        <kwd>glibenclamide</kwd>
        <kwd>glycosylated hemoglobin</kwd>
        <kwd>glucose</kwd>
        <kwd>Insulin</kwd>
        <kwd>hypoglycemia</kwd>
      </kwd-group>
      <kwd-group xml:lang="ru">
        <kwd>диабет</kwd>
        <kwd>гипергликемия</kwd>
        <kwd>Глибенкламид</kwd>
        <kwd>гликозилированный гемоглобин</kwd>
        <kwd>глюкоза</kwd>
        <kwd>инсулин</kwd>
        <kwd>гипогликемия</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>А.С. Аметов. Сахарный диабет 2 типа. Проблемы и решения. Учебное пособие 2015г</mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation>А.В.Древаль. Сахарный диабет популярная для больных дибетом 2015г</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>И.И.Дедов. Эндокринология 2010г</mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation>Дэвид Гарднер.Базисная и клиническая эндокринология. Книга 2 2020 г</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation>И.И. Дедов.Справочник детского эндокринолога. 2011г</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation>Narmetova, S. Y., &amp; Mardiyeva, J. S. (2023). The Advantage of the Drug Nifedipine in the Treatment of Arterial Hypertension. American Journal of Language, Literacy and Learning in STEM Education (2993-2769), 1(6), 280-282.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation>Юлдашев С. Ж., Халимбетов Ю. М., Нарметова С. Я. ЭКОЛОГИЧЕСКАЯ ВОСПИТАТЕЛЬНАЯ РАБОТА С МОЛОДЁЖЬЮ В НОВОМ УЗБЕКИСТАНЕ //Биологические науки: традиции, достижения, инновации. – 2023. – С. 19-20.</mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation>Narmetova S. Y. et al. EFFECTIVENESS OF THE DRUG L-MONTUS (MONTELUKAST) IN THE TREATMENT OF BRONCHIAL ASTHMA //Central Asian Journal of Medical and Natural Science. – 2024. – Т. 5. – №. 1. – С. 489-492.</mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation>Narmetova S. Y., Mardiyeva J. S. The Advantage of the Drug Nifedipine in the Treatment of Arterial Hypertension //American Journal of Language, Literacy and Learning in STEM Education (2993-2769). – 2023. – Т. 1. – №. 6. – С. 280-282.</mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation>Narmetova S. Y. et al. Effectiveness of the Use of the Drug Erinite in the Prevention of Stenocardial Attacks in Patients //Research Journal of Trauma and Disability Studies. – 2024. – Т. 3. – №. 2. – С. 111-113.</mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation>Murodovna J. D., Bakhodirovna S. D., Yangiboyevna N. S. Learning Liquid Medicine Forms and Writing Prescriptions for Medical School Students //Central Asian Journal of Medical and Natural Science. – 2022. – Т. 3. – №. 5. – С. 72-76.</mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation>Rajabboevna, A. R., Yangiboyevna, N. S., Farmanovna, I. E., &amp; Baxodirovna, S. D. (2022). The importance of complex treatment in hair loss.</mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation>Rajabboevna, A. R., &amp; Yangiboyevna, N. S. (2023). EPILEPSIYA BILAN OG&apos;RIGAN BEMORLARDA TOPAMAX DORI VOSITASINING KLINIK VA FARMAKOEKONOMIK ASPEKTLARINING SAMARADORLIGINI BAHOLASH. Research Focus International Scientific Journal, 2(5), 198-202.</mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation>Yangiboyevna, N. S. (2024). SUBSTANCES AFFECTING UTERUS MUSCLES. American Journal of Pediatric Medicine and Health Sciences (2993-2149), 2(2), 374-381.</mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation>Narmetova, S. Y. (2024). EFFECTIVENESS OF THE DRUG L-MONTUS (MONTELUKAST) IN THE TREATMENT OF BRONCHIAL ASTHMA. Central Asian Journal of Medical and Natural Science, 5(1), 489-492.</mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation>Narmetova, S. Y. (2024). Effectiveness of the Use of the Drug Erinite in the Prevention of Stenocardial Attacks in Patients. Research Journal of Trauma and Disability Studies, 3(2), 111-</mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation>Narmetova, S. Y., &amp; Mardiyeva, J. S. (2023). The Advantage of the Drug Nifedipine in the Treatment of Arterial Hypertension. American Journal of Language, Literacy and Learning in STEM Education (2993-2769), 1(6), 280-282.</mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation>Narmetova, S. Y. (2024). EFFECTIVENESS OF THE DRUG L-MONTUS (MONTELUKAST) IN THE TREATMENT OF BRONCHIAL ASTHMA. Central Asian Journal of Medical and Natural Science, 5(1), 489-492.</mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation>Yangiboyevna, N. S., &amp; Ravshanovna, M. U. (2022). BIOLOGIK FAOL QO&apos;SHIMCHALARNING TIBBIYOTDAGI AHAMIYATI. BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI, 542-545.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
